Answers are grounded in this paper and cite their sources.
In 2020-2022, the pandemic of the novel coronavirus infection became the main medical, economic, and political concern in the world. Disregulated immune system, unbalanced cytokine production is one of the distinctive characteristics of SARS-CoV-2 influence on human organism. Immunological aspects of the infection are still understudied. The main prognostic biomarkers of the novel coronavirus infection course are Interleukin 6 and ferritin. Their role in the development of antiviral response is so far unclear. Thus, further studies of clinical, pathophysiological and immunological developmental variants of the novel coronavirus infection are currently important.
No takes yet. Share an insight, caveat, or question.
Костенко et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: